Luke JJ, Piha-Paul SA, Medina T, Verschraegen CF, Varterasian M, Brennan AM, et al
Health Canada has approved new brand names for Novo Nordisk's semaglutide products, marking a strategic regulatory move as the Danish pharmaceutical giant prepares for generic competition in the Canadian market
That's brand-stated language, and it's worth reading closely: almost every claim on the site is hedged with "may" - may include, may be guided by, may be tailored
VNS has shown promise in reducing anxiety and improving emotional regulation in individuals with autism
doi: 10.3389/fendo.2021.806819 Received 01 November 2021 Accepted 17 November 2021 Published 14 December 2021 Volume 12 - 2021 Edited by Fang Zhongze, Tianjin Medical University, China Reviewed by Lihong Ye, Nankai University, China
Obesity and weight management: How environmental factors contribute to energy imbalance